At a glance
- Independent information and advice, with no sponsorship.
- This is an information website, not a pharmacy, prescriber or clinical service.
- Sources and an editorial update date are not proof of a clinician’s review.
- Use the editorial policy, source links and commercial disclosure to assess a page.
What you can find here
The guide library covers Mounjaro, Wegovy injections and tablets, Ozempic, Foundayo and the wider GLP-1 medicine class. It separates treatment evidence from practical topics such as food, hydration, travel, storage, identity checks and recognising a questionable supply.
The tools explain their arithmetic. Pen tools count labelled injections and entered prices. They do not choose treatment, confirm an injection dose from clicks or treat residual liquid as an extra dose. The protein tool illustrates weight-based estimates and their limits.
The intended audience is UK adults seeking general information. A page cannot know a reader’s medical history, other medicines, examination findings or local care arrangements.
Publisher and review status
The publisher name shown on this website is GLP1Guide. A publisher label identifies the website responsible for the page; it does not establish medical qualifications. This edition does not name a qualified clinical reviewer, and an editorial source check must not be interpreted as an independent medical review.
Research, drafting and the local rebuild of this edition used AI assistance. That assistance can help organise information, but it can also make mistakes. Primary-source links are provided so that factual statements can be checked. A review badge or a polished page is not a substitute for checking whether the source supports the statement.
Where a named author or clinical reviewer is added, the page should identify the person, relevant role and actual contribution. Until those details are established, we do not fill the gap with an invented profile or credential. Google’s guidance also encourages accurate authorship information and rejects deceptive expertise claims. [1]
How to read sources and dates
A source link should take you to the particular leaflet, decision, warning or study being discussed. A UK licence does not by itself establish that a medicine is on the NHS or in stock at a pharmacy. A trial result is not a prediction for an individual.
The editorial update date records substantive changes to this edition. It does not certify that every external link remains unchanged afterwards. Product instructions and healthcare guidance can be revised, so read the current leaflet supplied with your medicine and ask a pharmacist when a presentation or instruction differs.
The editorial policy explains the source hierarchy, uncertainties, corrections and AI assistance in more detail.
External links, relationships and corrections
GLP1Guide links to official information, research, practical resources and some external comparison or tracking services. A link is not proof of regulatory approval, an endorsement of every listed provider or evidence that the linked service is independent of this website. Read the commercial disclosure.
If a sentence appears wrong, contact the website with the page address and the statement in question. A direct source is helpful. Please send website corrections rather than medical records or requests for a prescribing decision. The contact and corrections page explains what to include.
Questions and answers
Is GLP1Guide sponsored?
Does GLP1Guide prescribe medicines?
Has every page been medically reviewed?
Can I rely on an update date alone?
Sources
Sources consulted for this editorial update: 28 October 2026. Follow the link for the source’s own revision date.
- Google Search Central: helpful, reliable contentAuthorship and evidence guidance for publishers; not a medical credential.